Coexistence of prothrombic risk factors and its relation to left ventricular thrombus in acute myocardial infarction

References

• Asinger RW, Mike11 FL, Elsperger J, Hodges M. Incidence of left ventricular thrombosis after acute transmural myocar-dial infarction: serial evaluation by two-dimensional echocar-diography. N Engl J Med 1981; 305: 297–302.
   Google Scholar
• van Dantzig JM, Delemarre BJ, Bot H, Visser CA. Left ven-tricular thrombus in acute myocardial infarction. Eur Heart J 1996; 17: 1640–5.
   Google Scholar
• Weinreich DJ, Burke JF, Pauletto FJ. Left ventricular mural thrombi complicating acute myocardial infarction: long-term follow-up with serial echocardiography. Ann Intern Med 1984; 100: 789–94.
   Google Scholar
• Virchow R. Gesammelte Abhandlungen zur wissenchaft-lichen Medizin. Frankfurt Meidinger Sohn; 1856: 219–732.
   Google Scholar
• Stormorken H, Sakariassen KS. Hemostatic risk factors in arterial thrombosis and atherosclerosis: the thrombin-fibrin and platelet-vWF axis. Thromb Res 1997; 88: 1–25.
   Google Scholar
• Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosen-berg RD. Increased activation of the haemostatic system in men at high risk of fatal coronary artery disease. Thromb Haemost 1996; 75: 767–71.
   Google Scholar
• Gowda MS, Zucker ML, Vacek JL, Carriger WL, Van Laeys DL, Rachel JM, Strope BD. Incidence of factor V Leiden in patients with acute myocardial infarction. J Thromb Thrombolysis 2000; 9: 43–5.
   Google Scholar
• Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dir-ven RJ, de Ronde H, van der Velden PA, Reitsma PH. Muta-tion in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64–7.
   Google Scholar
• Holm J, Zöller B, Svensson PJ, Berntrop E, Erhardt L, Dahlback B. Myocardial infarction associated with homozy-gous resistance to activated protein C. Lancet 1994; 344: 952.
   Google Scholar
• Voetsch B, Damasceno BP, Camargo EC, Massaro A, Bach-eschi LA, Scaff M, Annichino-Bizzacchi JM, Arruda VR. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 2000; 83: 229–33.
   Google Scholar
• çelik S, Ovali E, Baykan M, Uçar F, Erdöl C, Durmus I, Kaplan S. Factor V Leiden and its relation to left ventricu-lar thrombus in acute myocardial infarction. Acta Cardiol 2001; 56: 1–6.
   Google Scholar
• Cattaneo M, Chantarangkul V, Taioli E, Santos JH, Tagli-abue L. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein throm-bosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma pro-thrombin levels. Thromb Res 1999; 93(1): 1–8.
   Google Scholar
• Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A com-mon genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma pro-thrombin levels and an increase in venous thrombosis. Blood 1996; 88(10): 3698–703.
   Google Scholar
• Linfert DR, Tsongalis GJ. Coexistence of the methylenete-trahydrofolate reductase single-nucleotide polymorphism (C677T) in patients with the factor V Leiden or prothrom-bin G20210A polymorphisms. Diagn Mol Pathol 2001; 10: 111–5.
   Google Scholar
• Akar N, Akar E, Misirlioglu M, Avcu F, Yalcin A, Cin S. Search for genetic factors favoring thrombosis in Turkish population. Thromb Res 1998; 92: 79–82.
   Google Scholar
• Lopaciuk S, Bykowska K, Kwiecinski H, Mickielewicz A, Czlonkowska A, Mendel T, Kuczynska-Zardzewialy A, Szelagowska D, Windyga J, Schroder W, Herrmann FH, Jedrzejowska H. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost 2001; 7: 346–50.
   Google Scholar
• Kang SS, Zhou J, Wong PWK, Kowalisyn J, Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988; 43: 414–21.
   Google Scholar
• Hessner MJ, Dinauer DM, Luhm RA, Endres JL, Mont-gomery RR, Friedman KD. Contribution of the glycopro-tein Ia 807TT, methylene tetrahydrofolate reductase 677TT and prothrombin 20210GA genotypes to prothrombotic risk among factor V 1691GA (Leiden) carriers. Br J Haematol 1999; 106: 237–9.
   Google Scholar
• Akar N, Akar E, Akcay R, Avcu F, Yalcin A, Cin S. Effect of methylenetetrahydrofolate reductase 677 C-T, 1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients. Thromb Res 2000; 97: 163–7.
   Google Scholar
• Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al. A candidate genetic risk factor for vas-cular disease: a common mutation in methylenetetrahydro-folate reductase. Nat Genet 1995; 10: 111–3.
   Google Scholar
• Schiller N, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I et al. Recommendation for quantitation of the left ventri-cle by two dimensional echocardiography. J Am Soc Echocar-diogr 1989; 2: 358–68.
   Google Scholar
• Marz W, Seydewitz H, Winkelmann B, Chen M, Nauck M, Witt I. Mutation in coagulation factor V associated with resistance to activated protein C. Lancet 1995; 345: 526–7.
   Google Scholar
• Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kaup-pinen-Mäkelin R, Hämäläinene L, Palomaki H, Kaste M. Arg 506Gln Factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995; 73: 558.
   Google Scholar
• Emmerich J, Poirier 0, Evans A Marques-Vidal P, Arveiler D, Luc G, Aiach M, Cambien F. Myocardial infarc-tion, Arg506 to Gin factor V mutation, and activated pro-tein C resistance. Lancet 1995; 345: 321.
   Google Scholar
• Van Bockxmeer FM, Baker RI, Taylor RR. Premature ischaemic heart disease and the gene for coagulation factor V Nat Med 1995; 1: 185.
   Google Scholar
• Ridker PM, Hennekens CH, Lindpainter K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912–7.
   Google Scholar
• Brown K, Luddington R, Williamson D, Baker P, Baglin T. Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3’-untrans-lated region of the prothrombin gene. Br J Haematol 1997; 98: 907–9.
   Google Scholar
• Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997; 5: 1747–50.
   Google Scholar
• Doggen CJM, Manger Cats V, Bertina RM, Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 1998; 97: 1037–41.
   Google Scholar
• Kang SS, Wong PWK, Bock HG, Horwitz A, Grix A. Inter-mediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase muta-tions. Am J Hum Genet 1991; 38: 546–51.
   Google Scholar
• Arruda VR, von Zuben PM, Chiaparini LC, Annichino-Bizzacchi JM, Costa FF. The mutation Ala677 to Val in the methylene tetrahydrofolate reducatase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 1997; 77: 818–21.
   Google Scholar
• Salamon 0, Dardik R, Zivelin A. Homozygous methyl-enetetrahydrofolate reductase thermolability (MTHFR-T) is an independent risk factor for idiopathic deep-vein throm-bosis (DVT). Thromb Haemost 1997; suppl: 568–569.
   Google Scholar
• Alhenc-Gelas M, Arnaud E, Nicaud V, Aubry ML, Fiessinger JN, Aiach M, Emmerich J. Venous thromboem-bolic disease and the prothrombin, methylenetetrahydrofo-late reductase, and factor V genes. Thromb Haemost 1999; 81: 506–10.
   Google Scholar
• Cattaneo M, Tsai MY, Bucciarelli P, Taioli E, Zighetti ML, Bignell M, Mannucci PM. A common mutation in the meth-ylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant fac-tor V (factor V:Q506). Arterioscler Thromb Vasc Biol 1997; 17: 1662–6.
   Google Scholar
• Kluijtmans LA, van den Heuvel LP, Boers GH, Frosst P, Stevens EM, van Oost BA, den Meijer M, Trijbels FJ, Rozen R, Blom HJ. Molecular genetic analysis in mild hyper-homocysteinemia: a common mutation in the methylenete-trahydrofolate gene is a genetic risk factor for cardiovascu-lar disease. Am J Hum Genet 1996; 58: 45–41.
   Google Scholar
• Izumi M, Iwai N, Ohmichi N, Nakamura Y, Shimoike H, Kinoshita M. Molecular variant of 5,10-methylenetetrahy-drofolate reductase is a risk factor of ischemic heart disease in the Japanese population. Atherosclerosis 1996; 121: 293–4.
   Google Scholar
• Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R. Methyl-enetetrahydrofolate reductase polymorphism, plasma folate, homocysteine and risk of myocardial infarction in US physi-cians. Circulation 1996; 94: 2410–6.
   Google Scholar
• Verhoef P, Kok FJ, Kluitmans LAJ, Blom HJ, Refsum H, Ueland PM, Kruyssen DACM. The 677CT mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary ath-erosclerotic disease. Atherosclerosis 1997; 132: 105–13.
   Google Scholar
• Anderson JL, King GJ, Thomson MJ, Todd M, Bair T, Muhlestein JB, Carlquist JF. A mutation in the methyl-enetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. J Am Coll Cardiol 1997; 30: 1206–11.
   Google Scholar
• Ilken DEL, Wang XL, Sim AS, McCredie RM. Distribu-tion in healthy and coronary populations of the methyl-enetetrahydrofolate reductase (MTHFR) mutation. Arte-rioscler Thromb Vasc Biol 1996; 16: 878–82.
   Google Scholar
• Visser CA, Kan G, Meltzer RS, Lie KI, Durrer D. Long-term follow-up of left ventricular thrombus after acute myocardial infarction: a two-dimensional echocardiographic study in 96 patients. Chest 1984; 86: 532–6.
   Google Scholar
• Domenicucci S, Chiarella F, Bellotti P, Lupi G, Scarsi G, Vecchio C. Early appearance of left ventricular thrombi after anterior myocardial infarction: a marker of higher in-hos-pital mortality in patients not treated with antithrombotic drugs. Eur Heart J 1990; 11: 51–8.
   Google Scholar